3-Chloro-6-({[3-(trifluoromethyl)phenyl]methyl}sulfanyl)-[1,2,4]triazolo[4,3-b]pyridazine

Catalog No. :
ACQLJR184
CAS No. :
303996-19-2
Molecular Formula :
C13H8ClF3N4S
Molecular Weight :
344.75

IUPAC Name:3-chloro-6-((3-(trifluoromethyl)benzyl)thio)-[1,2,4]triazolo[4,3-b]pyridazine

3-Chloro-6-({[3-(trifluoromethyl)phenyl]methyl}sulfanyl)-[1,2,4]triazolo[4,3-b]pyridazine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g90%$324.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3-Chloro-6-({[3-(trifluoromethyl)phenyl]methyl}sulfanyl)-[1,2,4]triazolo[4,3-b]pyridazine
IUPAC Name3-chloro-6-((3-(trifluoromethyl)benzyl)thio)-[1,2,4]triazolo[4,3-b]pyridazine
MDL No.MFCD00139674
Molecular FormulaC13H8ClF3N4S
Molecular Weight344.75
SMILESFC(C1=CC(CSC2=NN3C(C=C2)=NN=C3Cl)=CC=C1)(F)F
InChI KeyXJVRNMDIBMURDE-UHFFFAOYSA-N
Synonym3-CHLORO-6-([3-(TRIFLUOROMETHYL)BENZYL]SULFANYL)[1,2,4]TRIAZOLO[4,3-B]PYRIDAZINE;3-CHLORO[1,2,4]TRIAZOLO[4,3-B]PYRIDAZIN-6-YL 3-(TRIFLUOROMETHYL)BENZYL SULFIDE;3-chloro-6-({[3-(trifluoromethyl)phenyl]methyl}sulfanyl)-[1,2,4]triazolo[4,3-b]pyridazine;1,2,4-Triazolo[4,3-b]pyridazine, 3-chloro-6-[[[3-(trifluoromethyl)phenyl]methyl]thio]-
CAS No.303996-19-2

Synthetic Route by SureRoute

1. ACQLJR184 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACQZJO765 route compound structure diagram
    ACQZJO76533050-38-3 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACQLJR184 route product structure diagram
    ACQLJR184303996-19-2
Inquiry

2. ACQLJR184 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACQLJR184 route product structure diagram
    ACQLJR184303996-19-2
Inquiry

Comments (0)